03.12.2025 • News

IMCD Announces New Global Leader for Food & Nutrition Business Group

Emmanuel Colette will assume global leadership of IMCD's Food & Nutrition business group with effect from March 1, 2026, in addition to his current position as Managing Director, IMCD France.

Photo
Emmanuel Colette, IMCD
© IMCD

In his expanded role, Emmanuel Colette will guide the global development of Food & Nutrition, strengthening its commercial and technical offering and accelerating the Business Group’s contribution to IMCD’s growth ambitions. 

Holding previous management roles in Tipiak and Agrana, Emmanuel joined the Rotterdam, The Netherlands-based global distribution and formulation partner of speciality chemicals and ingredients, IMCD, in 2012 as product manager, Food & Nutrition, and was appointed as international product manager in 2018. In 2020, he moved to Singapore to lead Food & Nutrition in Asia Pacific and serve as managing director of IMCD Singapore. During his time in Asia, Emmanuel helped double the Food & Nutrition business through organic growth, supplier expansion and the acquisition of EurochemoPharma in Malaysia. He has been managing director of IMCD France since March 2024. 

Emmanuel Colette will be replacing Marc van Gerwen who will retire on 1st March 2026 after a career spanning 38 years in the chemicals and ingredients industry.

Marcus Jordan, CEO of IMCD, comments: “Emmanuel Colette on has been successful in every step of his career through the trust he builds with his teams and his strong track record of delivery. I am confident Emmanuel will bring the same energy and leadership to Food & Nutrition and continue to drive our growth globally. Congratulations to him as he takes over from Marc van Gerwen, under whose leadership the Business Group has grown significantly and strengthened its position across regions. We wish Marc all the very best in retirement.”

Company

Logo:

IMCD Group B.V.

Wilhelminaplein 32
3072 Rotterdam
Netherlands

Company contact







Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

Interview

Stability in Motion
Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.

most read